<DOC>
	<DOC>NCT00073476</DOC>
	<brief_summary>The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>Males &amp; females age 4090 years Enrolled in study within 6 hours of onset of stroke symptoms Willing to sign informed consent form No significant disabilities prior to stroke Treatment with tPA (tissue plasminogen activator) Premorbid modified rankin scale score of 2 or more</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>